Literature DB >> 32043227

A decade of FRAX: how has it changed the management of osteoporosis?

John A Kanis1,2, Nicholas C Harvey3, Helena Johansson4,5, Enwu Liu5, Liesbeth Vandenput6, Mattias Lorentzon5,6, William D Leslie7, Eugene V McCloskey4,8.   

Abstract

The fracture risk assessment tool, FRAX®, was released in 2008 and provides country-specific algorithms for estimating individualized 10-year probability of hip and major osteoporotic fracture (hip, clinical spine, distal forearm, and proximal humerus). Since its release, 71 models have been made available for 66 countries covering more than 80% of the world population. The website receives approximately 3 million visits annually. Following independent validation, FRAX has been incorporated into more than 80 guidelines worldwide. The application of FRAX in assessment guidelines has been heterogeneous with the adoption of several different approaches in setting intervention thresholds. Whereas most guidelines adopt a case-finding strategy, the case for FRAX-based community screening in the elderly is increasing. The relationship between FRAX and efficacy of intervention has been explored and is expected to influence treatment guidelines in the future.

Entities:  

Keywords:  Clinical risk factors; FRAX; Fracture probability; Intervention thresholds; Risk assessment; Screening

Mesh:

Year:  2020        PMID: 32043227     DOI: 10.1007/s40520-019-01432-y

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  26 in total

Review 1.  Role of bone-forming agents in the management of osteoporosis.

Authors:  Michael R McClung
Journal:  Aging Clin Exp Res       Date:  2021-02-16       Impact factor: 3.636

2.  FRAX and ethnicity.

Authors:  J A Kanis; C Cooper; B Dawson-Hughes; N C Harvey; H Johansson; M Lorentzon; E V McCloskey; J-Y Reginster; R Rizzoli
Journal:  Osteoporos Int       Date:  2020-09-04       Impact factor: 4.507

Review 3.  Management of osteoporosis in older men.

Authors:  Jean-Marc Kaufman
Journal:  Aging Clin Exp Res       Date:  2021-04-05       Impact factor: 3.636

Review 4.  Early-stage symptomatic osteoarthritis of the knee - time for action.

Authors:  Armaghan Mahmoudian; L Stefan Lohmander; Ali Mobasheri; Martin Englund; Frank P Luyten
Journal:  Nat Rev Rheumatol       Date:  2021-08-31       Impact factor: 20.543

5.  FAMILY HISTORY - BMD INDEPENDENTLY - INFLUENCES FRACTURE RISK.

Authors:  A Gasparik; T Szőcs; I Pascanu; Z Csata; C Poiana
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

6.  Risk factors for imminent fractures: a substudy of the FRISBEE cohort.

Authors:  L Iconaru; M Moreau; F Baleanu; V Kinnard; A Charles; A Mugisha; M Surquin; F Benoit; R Karmali; M Paesmans; J J Body; P Bergmann
Journal:  Osteoporos Int       Date:  2021-01-07       Impact factor: 4.507

7.  A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis.

Authors:  E Söreskog; F Borgström; I Lindberg; O Ström; D Willems; C Libanati; J A Kanis; B Stollenwerk; M Charokopou
Journal:  Osteoporos Int       Date:  2021-01-07       Impact factor: 4.507

Review 8.  Which treatment to prevent an imminent fracture?

Authors:  Iconaru Laura; Baleanu Felicia; Charles Alexia; Mugisha Aude; Benoit Florence; Surquin Murielle; Karmali Rafik; Body Jean-Jacques; Bergmann Pierre
Journal:  Bone Rep       Date:  2021-07-09

9.  Seasonal Variation and Global Public Interest in the Internet Searches for Osteoporosis.

Authors:  Chao Wang; Xiong Shu; Jianfeng Tao; Yanzhuo Zhang; Yue Yuan; Chengai Wu
Journal:  Biomed Res Int       Date:  2021-06-04       Impact factor: 3.411

10.  FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine.

Authors:  Vladyslav Povoroznyuk; Nataliia Grygorieva; Helena Johansson; Mattias Lorentzon; Nicholas C Harvey; Eugene V McCloskey; Anna Musienko; Enwu Liu; John A Kanis; Nataliia Zaverukha; Oksana Ivanyk
Journal:  J Osteoporos       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.